ChemAnalyst

According to ChemAnalyst, The Amphotericin B prices remained largely stable during the second quarter of 2026, with only marginal quarter-over-quarter increases across major global markets. While the pharmaceutical industry continued to face moderate logistical expenses, regulatory compliance costs, and fluctuating production inputs, the overall pricing environment remained balanced due to steady manufacturing output and consistent demand from hospitals and healthcare institu

Introduction to Amphotericin B Market Dynamics Amphotericin B is a critical antifungal medication widely used in the treatment of severe systemic infections. Due to its life-saving importance and complex manufacturing process, the Amphotericin B market is highly sensitive to supply chain disruptions, regulatory frameworks, and raw material availability. In recent quarters, global pricing trends have shown moderate upward movement, reflecting tightening supply conditions and

Executive Summary The Amphotericin B Prices witnessed a modest yet steady upward movement across key global markets during the quarter ending December 2025. The global antifungal pharmaceutical segment continued to experience constrained supply conditions, firm procurement patterns, and ongoing logistics pressures. Across North America, Asia-Pacific (APAC), and Europe, the Amphotericin B Price Index recorded quarterly increases ranging between 0.51% and 0.56%, indicating ti